Management of Neuropathic Pain After Myelitis Without Prompt Steroid Treatment
For neuropathic pain following myelitis without prompt steroid treatment, first-line therapy should be gabapentin, which provides good pain relief with 3-4 out of 10 patients achieving at least 50% pain reduction. 1
First-Line Pharmacological Options
Gabapentinoids
- Gabapentin: Start at low dose (100-300mg daily) and titrate gradually to effective dose (1800-3600mg daily in divided doses)
- Pregabalin: Alternative to gabapentin with potentially fewer cognitive side effects; start at 25-50mg daily and titrate slowly 1
Other First-Line Options
- Duloxetine: Consider as next therapeutic option if gabapentinoids are ineffective; start at 30mg daily for one week, then increase to 60mg daily if tolerated 1
- Topical lidocaine: 5% patches applied to painful areas for up to 12 hours daily for localized pain 1
Second-Line Pharmacological Options
- Amitriptyline: Start at low dose (10mg at bedtime) if duloxetine is ineffective; use with caution in elderly due to anticholinergic effects 1
- Compounded amitriptyline-ketamine mixture: Amitriptyline 1-2% and ketamine 0.5-5% applied up to 3 times daily for localized pain 1
Advanced Interventions for Refractory Pain
Spinal Cord Stimulation
- Consider for intractable neuropathic pain unresponsive to medical treatment
- Has shown improvement in pain scores, medication usage, and daily function in patients with myelitis-related neuropathic pain 2, 3
Immunomodulatory Therapy
- For patients with ongoing inflammatory component:
Non-Pharmacological Interventions
- Physical therapy: Strengthening exercises, range of motion exercises, proper body mechanics, and postural training 1
- Cognitive behavioral therapy: Helps develop adaptive coping strategies for chronic pain 1
- Heat/cold therapy: Limited ice application (10 minutes, 4 times daily) may provide relief 1
- Transcutaneous electrical nerve stimulation (TENS): May provide modest adjunctive benefit 1
Treatment Algorithm
- Start with gabapentin as first-line therapy
- If inadequate response after 4-6 weeks of optimal dosing:
- Add or switch to duloxetine
- If still inadequate response:
- Consider amitriptyline or topical agents
- For refractory cases:
- Consider referral for spinal cord stimulation evaluation
- Consider immunomodulatory therapy if ongoing inflammatory component suspected
Important Considerations
- Avoid corticosteroids in purely motor demyelinating neuropathy as they may worsen symptoms 4
- Regular assessment of treatment efficacy and side effects is crucial 1
- Adjust dosages based on renal function, age, and comorbidities 1
- Refer to neurology if symptoms persist or worsen despite intervention 1
Cautions
- Steroid treatment should be used with caution in purely motor forms of acquired demyelinating polyneuropathy, as it may unexpectedly increase weakness 4
- NSAIDs should be avoided in patients with renal impairment due to risk of worsening renal function 1
- Long-term opioid therapy for chronic pain should be avoided when possible 1
By following this structured approach to managing neuropathic pain after myelitis, patients can achieve better pain control and improved quality of life.